Modulation of T-regulatory cells by small molecules: potential therapy for GvHD
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is often curative for patients suffering from blood cancers. Nonetheless, significant morbidity and mortality are still prevalent. One major complication is graft versus host disease (GvHD) which occurs in 30-70% of patients. In this dis...
Huvudupphovsman: | Leuschner, U |
---|---|
Övriga upphovsmän: | Roberts, D |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
2021
|
Liknande verk
Liknande verk
-
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
av: Mauro Di Ianni, et al.
Publicerad: (2024-01-01) -
The Role of Bacteria and Pattern Recognition Receptors in GvHD
av: E. Holler, et al.
Publicerad: (2010-01-01) -
Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells
av: Haroon Shaikh, et al.
Publicerad: (2022-11-01) -
Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
av: Martin eSzyska, et al.
Publicerad: (2016-03-01) -
Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
av: Kudakwashe Mhandire, et al.
Publicerad: (2021-10-01)